| RS370820880 |
TONSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TONSL-related disorder |
| RS370821927 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Occipital pachygyria and polymicrogyria, Occipital pachygyria and polymicrogyria |
| RS370822722 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS370823127 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS370823171 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS370823298 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS370824570 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
ALS2-related disorder, Amyotrophic lateral sclerosis type 2 |
| RS370826757 |
SLC34A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive hypophosphatemic bone disease, Inborn genetic diseases |
| RS370827246 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, PEX5-related disorder |
| RS370827464 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS370828258 |
VPS53
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 2E, Pontocerebellar hypoplasia type 2E |
| RS370828455 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS370828525 |
NTRK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS370830238 |
PPARG
|
Health Risk |
Conflicting classifications of pathogenicity |
PPARG-related familial partial lipodystrophy, Obesity |
| RS370830603 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS370831760 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Microcephaly 1 |
| RS370832130 |
VPS13C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS370833765 |
CBLIF
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary intrinsic factor deficiency, CBLIF-related disorder |
| RS370834231 |
PPP2R5D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PPP2R5D-related disorder |
| RS370834297 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS370834972 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypersulfaturia, Nephrolithiasis susceptibility caused by SLC26A1 |
| RS370834994 |
C5
|
Health Risk |
Conflicting classifications of pathogenicity |
Eculizumab, poor response to |
| RS370835373 |
MYT1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS370835731 |
BEST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS370837823 |
GNPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS370837898 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS370837940 |
ZFYVE26
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS370838091 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS370838225 |
BGN
|
Health Risk |
Conflicting classifications of pathogenicity |
BGN-related disorder, BGN-related disorder |
| RS370838557 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS370838704 |
CD151
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 7, with nephropathy and deafness |
| RS370839320 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 4, Brugada syndrome 4 |
| RS370840009 |
KIAA0753
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofaciodigital syndrome XV, KIAA0753-related disorder |
| RS370840119 |
PRKCSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic liver disease 1, Inborn genetic diseases |
| RS370840449 |
EMD
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Emery-Dreifuss muscular dystrophy, Emery-Dreifuss muscular dystrophy |
| RS370841672 |
IL10RB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 25, Inborn genetic diseases |
| RS370842354 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperuricemia, pulmonary hypertension |
| RS370842677 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS370842740 |
MCPH1
|
Health Risk |
Pathogenic |
Autosomal recessive primary microcephaly, Autosomal recessive primary microcephaly |
| RS370843758 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, Merosin deficient congenital muscular dystrophy |
| RS370844834 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Finnish congenital nephrotic syndrome |
| RS370845582 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS370846070 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS370847346 |
XPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group C |
| RS370847523 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS370847935 |
BMP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia with brain and digit anomalies, Orofacial cleft 11 |
| RS370848188 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS370848887 |
POLA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS370849006 |
BBS5
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 5 |
| RS370849059 |
DIAPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, Autosomal dominant nonsyndromic hearing loss 1 |
| RS370850432 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
RAI1-related disorder, RAI1-related disorder |
| RS370850456 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS370850533 |
VIPAS39
|
Health Risk |
Conflicting classifications of pathogenicity |
VIPAS39-related disorder, VIPAS39-related disorder |
| RS370850999 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS370851726 |
ADSL
|
Health Risk |
Likely pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS370851779 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS370851836 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS370852681 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS370853512 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS370854023 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
von Willebrand disease type 2, von Willebrand disease type 2 |
| RS370854090 |
SYN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, X-linked 1 |
| RS370854451 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS370855180 |
TANC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS370855899 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS370856494 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS370857029 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS370857637 |
PRKCSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Polycystic liver disease 1 |
| RS370857722 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, 6 conditions |
| RS370857813 |
ANKRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD1-related dilated cardiomyopathy, Cardiovascular phenotype |
| RS370857842 |
GNPTG
|
Health Risk |
Conflicting classifications of pathogenicity |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS370857858 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS370858405 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS370858630 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS370859689 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS370860479 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS370860489 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS370861322 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS370861594 |
ATP6V0A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular acidosis, distal |
| RS370861938 |
LOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 10 |
| RS370862113 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS370862426 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS370862494 |
ERCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group D |
| RS370862741 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS370862961 |
CTSC
|
Health Risk |
Conflicting classifications of pathogenicity |
Haim-Munk syndrome, Papillon-Lefèvre syndrome |
| RS370863694 |
TPI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Triosephosphate isomerase deficiency, TPI1-related disorder |
| RS370863743 |
RMND1
|
Health Risk |
Pathogenic |
Mitochondrial disease, Combined oxidative phosphorylation defect type 11 |
| RS370864445 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS370864802 |
ARFGEF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS370865082 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS370865189 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile cortical hyperostosis, Osteogenesis imperfecta |
| RS370865328 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS370865377 |
EPOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS370865499 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS370865998 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS370866302 |
TRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation deficiency 35, Combined oxidative phosphorylation deficiency 35 |
| RS370866476 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS370866578 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS370866589 |
SMOC1
|
Health Risk |
Pathogenic |
Microphthalmia with limb anomalies, Microphthalmia with limb anomalies |
| RS370867825 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS370868080 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |